The FDA lifts the clinical hold on new patient enrollment in Biohaven's epilepsy drug trials.
The FDA halted new enrollment in Biohaven's epilepsy trials. Official notification or public company disclosure that the FDA cleared resumption of enrollment settles this.
Across 6 frontier models answering independently, the panel leans yes: the median is 67%.
They broadly agree, 12 points between Gemini at 74% and Claude at 62%.
Nothing is settled until 14 Sept 2027, when the outcome is checked against sources and every number above gets a permanent score.
What each one said
-
GeminiGoogle
Most clinical holds for non-fatal concerns are resolved within 12 months following protocol modifications.
google/gemini-3.8-flash · asked 14 Sept 202674% -
GPTOpenAI
Clinical holds are often resolved within a year once FDA-requested safety/data issues are addressed.
openai/gpt-5.6-terra · asked 14 Sept 202672% -
GrokxAI
Most enrollment holds lift in months after sponsor reply; 1yr window is ample unless fatal safety signal.
x-ai/grok-4.6 · asked 14 Sept 202672% -
ClaudeAnthropic
Long window (1yr) gives ample time for typical FDA clinical hold resolution processes to complete
anthropic/claude-sonnet-5 · asked 14 Sept 202662% -
DeepSeekDeepSeek
Clinical holds often lift within 1-2 years; Biohaven has incentive to resolve quickly, but no guarantee by deadline.
deepseek/deepseek-v4.1-flash · asked 14 Sept 202662% -
QwenAlibaba
Clinical holds typically resolve within 6-18 months; Biohaven has resources to address FDA concerns within this window.
qwen/qwen3.8-max-0902 · asked 14 Sept 202662%
6 of 6 models answered · 12 points between the highest and lowest. None was shown the market price.
Question sourced from a news sweep on 14 Sept 2026. Forecast by google/gemini-3.8-flash, anthropic/claude-sonnet-5, openai/gpt-5.6-terra, x-ai/grok-4.6, deepseek/deepseek-v4.1-flash, qwen/qwen3.8-max-0902 via OpenRouter.